Literature DB >> 25541844

Fournier's gangrene: review of 120 patients and predictors of mortality.

Tuncay Yılmazlar1, Özgen Işık2, Ersin Öztürk2, Ali Özer2, Barış Gülcü2, İlker Ercan3.   

Abstract

BACKGROUND: Fournier's gangrene (FG) is a devastating and potentially fatal disease requiring prompt and aggressive debridement. In this study, it was aimed to assess the predictors of mortality in a large cohort.
METHODS: Prospectively maintained data of patients with FG were analyzed. Demographic data, duration of symptoms, Uludag Fournier's Gangrene Severity Index (UFGSI) scores, co-morbidities [particularly diabetes mellitus (DM)], etiologies, number of debridement, stoma requirements, length of intensive care unit and hospital stay, and morbidity and mortality rates were reviewed. Multivariate analysis was performed in order to determine factors affecting mortality.
RESULTS: 120 patients (81 males) were included in the study. Median age was 58 (22-85) years. UFGSI score was median 9 (1-30). DM was present in 69 (57.5%) patients. Etiology of FG was perianal in fifty-nine, urogenital in 52, and skin in 9 patients. Median debridement count was 3 (1-12). Thirty-one patients required stoma. Forty-eight patients were admitted to intensive care unit and 25 patients required mechanical ventilation. Overall mortality rate was 20.8%. Multivariate analysis revealed UFGSI as the only predictor of mortality (p=0.001). Mortality rate was 13.64 times higher for patients with a UFGSI score of 9 or higher.
CONCLUSION: Fournier's gangrene is a mortal disease requiring emergency surgery. UFGSI is an efficient predictor of mortality for patients with FG.

Entities:  

Mesh:

Year:  2014        PMID: 25541844     DOI: 10.5505/tjtes.2014.06870

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  9 in total

1.  A different perspective for morbidity related to Fournier's gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier's gangrene?

Authors:  Ismail Selvi; Aykut Aykac; Ozer Baran; Salih Burlukkara; Ugur Ozok; Mehmet Melih Sunay
Journal:  Int Urol Nephrol       Date:  2019-06-08       Impact factor: 2.370

Review 2.  Rectal cancer and Fournier's gangrene - current knowledge and therapeutic options.

Authors:  Tomislav Bruketa; Matea Majerovic; Goran Augustin
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 3.  Deep tissue infection of the perineum: Case report and literature review of Fournier gangrene.

Authors:  Sarah N Faria; Anton Helman
Journal:  Can Fam Physician       Date:  2016-05       Impact factor: 3.275

4.  Fournier's gangrene: a modern analysis of predictors of outcomes.

Authors:  Jeffrey D Sparenborg; Jacob A Brems; Andrew M Wood; Jonathan J Hwang; Krishnan Venkatesan
Journal:  Transl Androl Urol       Date:  2019-08

5.  Unusual foreign body in the sigmoid colon, chronic alcohol abuse, and Fournier gangrene: a case report.

Authors:  Dietmar Schulz; Georgiana Simona Mohor; Caius Solovan
Journal:  Clin Interv Aging       Date:  2015-03-31       Impact factor: 4.458

6.  A Case of Fournier's Gangrene.

Authors:  Anthony Maurice Kordahi; Ahmed S Suliman
Journal:  Eplasty       Date:  2017-09-18

7.  Case series of Fournier's gangrene: Affected body surface area - The underestimated prognostic factor.

Authors:  Henrique Morais; Jessica Neves; Hugo Maciel Ribeiro; Marta Ferreira; Narcisa Guimarães; Nuno Azenha; Raquel Dias; Alice Fonseca; Lucilia Conceição
Journal:  Ann Med Surg (Lond)       Date:  2017-02-27

8.  Fournier Gangrene in a patient receiving chemo-radiation for rectal cancer.

Authors:  Maria Pittaka; Chrysanthos Georgiou; Petros Polyviou; Pantelis Kountourakis; Panayiotis Loizou; Ifigenia Constantinou; Demetris Andreopoulos; Vassilios P Vassiliou
Journal:  Oxf Med Case Reports       Date:  2018-02-26

9.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.